4//SEC Filing
Cannon Kara 4
Accession 0001213900-22-015627
CIK 0000316253other
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 6:03 PM ET
Size
12.4 KB
Accession
0001213900-22-015627
Insider Transaction Report
Form 4
Cannon Kara
DirectorChief Executive Officer
Transactions
- Award
Stock Option (to acquire Common Stock)
2022-03-24+87,500→ 87,500 totalExercise: $2.98From: 2023-03-24Exp: 2027-03-24→ Common Stock (87,500 underlying)
Holdings
- 55,400
Stock Option (to acquire Common Stock)
Exercise: $2.20From: 2021-02-24Exp: 2025-02-24→ Common Stock (55,400 underlying) - 52,000
Stock Option (to acquire Common Stock)
Exercise: $2.80From: 2020-01-03Exp: 2024-01-03→ Common Stock (52,000 underlying) - 87,500
Stock Option (to acquire Common Stock)
Exercise: $3.36From: 2023-02-11Exp: 2027-02-11→ Common Stock (87,500 underlying) - 22,614(indirect: By 401(k))
Common Stock, $0.01 Par Value
- 55,400
Stock Option (to acquire Common Stock)
Exercise: $2.63From: 2022-01-11Exp: 2026-01-11→ Common Stock (55,400 underlying) - 35,000
Stock Option (to acquire Common Stock)
Exercise: $4.42From: 2019-07-31Exp: 2023-07-30→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The stock options have a five-year term and will vest in three equal installments, one on the first anniversary of the grant date, the second on the second anniversary of the grant date and the third on the third anniversary of the grant date.
Documents
Issuer
ENZO BIOCHEM INC
CIK 0000316253
Entity typeother
Related Parties
1- filerCIK 0001913009
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 6:03 PM ET
- Size
- 12.4 KB